Clinical trials sponsored by Seagen, a wholly owned subsidiary of Pfizer
3
Recruiting trials
15
Conditions studied
Phase breakdown
Phase 1 2Phase 3 1
Conditions studied
Recruiting trials led by Seagen, a wholly owned subsidiary of Pfizer
- A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
- A Study of Sigvotatug Vedotin in Advanced Solid Tumors
- A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
Common questions
How many trials is Seagen, a wholly owned subsidiary of Pfizer recruiting for?
Seagen, a wholly owned subsidiary of Pfizer is the lead sponsor of 3 recruiting trials.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.